how often should you take glp-1 When to Titrate Up Your Dose GLP-1 Injection Schedule 2026: How

A Lithium GLP-1 Interaction More evidence of a serious drug interaction STUDY: Patarroyo-Rodriguez LP et al, J Clin Psychopharmacol 2026 STUDY TYPE: Case report FUNDING: National Center for Advancing Translational Science (NCATS) Background GLP-1 and GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound) cause nausea, vomiting, and dehydration, especially during dose escalation

Choosing the wrong ones can worsen nausea, accelerate muscle loss, and stall your progress

Research has also shown its use relieves multiple types of knee and other joint pain

Not necessarily providing a cure for alcohol-use disorder or compulsive gambling

2002;51(suppl 1):S271S283